Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT
Abstract Background Low-grade neuroendocrine tumors (NETs) are characterized by an abundance of somatostatin receptors (SSTR) that can be targeted with somatostatin analogs (SSA). When activated with a single dose of SSA, the receptor-ligand complex is internalized, and the receptor is by default re...
Enregistré dans:
Auteurs principaux: | Ulrika Jahn, Ezgi Ilan, Irina Velikyan, Katarzyna Fröss-Baron, Mark Lubberink, Anders Sundin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SpringerOpen
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f3e995fbfe0340859a0afc0a75e0b79b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
par: Peter Frøhlich Staanum, et autres
Publié: (2021) -
68Ga-P15-041, A Novel Bone Imaging Agent for Diagnosis of Bone Metastases
par: Rui Guo, et autres
Publié: (2021) -
Clinical use of Ortho-SUV transosseous hexapod in treatment of lower limb false joints
par: N. V. Tishkov, et autres
Publié: (2016) -
Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
par: Philippe Thuillier, et autres
Publié: (2021) -
Octreotide-Resistant Acromegaly: Challenges and Solutions
par: Corica G, et autres
Publié: (2020)